Retatrutide (RTA GLP-3) 10 mg
One of our featured catalog items. A sealed 10 mg lyophilized vial, cold-stored, with a 10-vial kit option that saves 30%.
About Retatrutide (RTA GLP-3) 10 mg
Retatrutide is a triple agonist peptide sequence targeting GIP, GLP-1, and glucagon receptors, developed as a research tool for studying combined incretin-receptor pathways. Supplied as a sealed, cold-stored lyophilized vial with a published Certificate of Analysis for each batch. The 10-vial kit format is intended for laboratories running extended or comparative research protocols.
At a glance
- • Product: Retatrutide (RTA GLP-3) 10 mg
- • Catalog information: Catalog specification published
- • Form: Sealed vial
- • Storage: Store at -20C. Protect from light.
- • Shipping: Ships from within the UK; most orders arrive in under 7 days after processing.
Quality & Laboratory Guidelines
Every batch of Retatrutide (RTA GLP-3) 10 mg undergoes rigorous dual HPLC and ESI-Mass Spectrometry analysis to guarantee >99.75% purity identity. Vials are vacuum-sealed under nitrogen atmosphere for optimal long-term shelf stability.
Important Notice
- • Compliance: Strictly for in-vitro research and laboratory testing only.
- • Restrictions: Not for human or animal consumption, medical treatment, or diagnostic use.
- • Verification: Batch purity certificates available upon request using your vial lot number.